nodes	percent_of_prediction	percent_of_DWPC	metapath
Alitretinoin—Vitamin A—RBP4—metabolic syndrome X	0.0171	0.901	CrCbGaD
Alitretinoin—Emotional distress—Metformin—metabolic syndrome X	0.00941	0.0503	CcSEcCtD
Alitretinoin—Acidosis—Metformin—metabolic syndrome X	0.00723	0.0386	CcSEcCtD
Alitretinoin—Hypothermia—Metformin—metabolic syndrome X	0.00714	0.0381	CcSEcCtD
Alitretinoin—Body temperature decreased—Metformin—metabolic syndrome X	0.00714	0.0381	CcSEcCtD
Alitretinoin—Gastrointestinal symptom NOS—Metformin—metabolic syndrome X	0.0068	0.0363	CcSEcCtD
Alitretinoin—Respiratory distress—Metformin—metabolic syndrome X	0.0063	0.0336	CcSEcCtD
Alitretinoin—Nail disorder—Metformin—metabolic syndrome X	0.00617	0.033	CcSEcCtD
Alitretinoin—Upset stomach—Metformin—metabolic syndrome X	0.00611	0.0326	CcSEcCtD
Alitretinoin—Contusion—Metformin—metabolic syndrome X	0.00458	0.0245	CcSEcCtD
Alitretinoin—Chest discomfort—Metformin—metabolic syndrome X	0.00452	0.0242	CcSEcCtD
Alitretinoin—RXRA—kidney—metabolic syndrome X	0.00431	0.116	CbGeAlD
Alitretinoin—CRABP2—adipose tissue—metabolic syndrome X	0.0039	0.105	CbGeAlD
Alitretinoin—RXRG—cardiovascular system—metabolic syndrome X	0.00386	0.104	CbGeAlD
Alitretinoin—Lightheadedness—Metformin—metabolic syndrome X	0.00358	0.0191	CcSEcCtD
Alitretinoin—RXRG—adipose tissue—metabolic syndrome X	0.00341	0.0915	CbGeAlD
Alitretinoin—Ear pain—Metformin—metabolic syndrome X	0.0034	0.0182	CcSEcCtD
Alitretinoin—Nasal congestion—Metformin—metabolic syndrome X	0.00319	0.017	CcSEcCtD
Alitretinoin—Renal impairment—Metformin—metabolic syndrome X	0.00305	0.0163	CcSEcCtD
Alitretinoin—RARA—kidney—metabolic syndrome X	0.00297	0.0797	CbGeAlD
Alitretinoin—Lethargy—Metformin—metabolic syndrome X	0.00296	0.0158	CcSEcCtD
Alitretinoin—Pain in extremity—Metformin—metabolic syndrome X	0.0029	0.0155	CcSEcCtD
Alitretinoin—RARG—adipose tissue—metabolic syndrome X	0.00284	0.0764	CbGeAlD
Alitretinoin—RXRA—liver—metabolic syndrome X	0.00272	0.0731	CbGeAlD
Alitretinoin—Dehydration—Metformin—metabolic syndrome X	0.0027	0.0144	CcSEcCtD
Alitretinoin—RARA—adipose tissue—metabolic syndrome X	0.00267	0.0718	CbGeAlD
Alitretinoin—Nasopharyngitis—Metformin—metabolic syndrome X	0.0026	0.0139	CcSEcCtD
Alitretinoin—Abdominal distension—Metformin—metabolic syndrome X	0.00253	0.0135	CcSEcCtD
Alitretinoin—Pancreatitis—Metformin—metabolic syndrome X	0.00246	0.0131	CcSEcCtD
Alitretinoin—RARB—liver—metabolic syndrome X	0.00245	0.0656	CbGeAlD
Alitretinoin—Sweating increased—Metformin—metabolic syndrome X	0.00244	0.0131	CcSEcCtD
Alitretinoin—Abdominal discomfort—Metformin—metabolic syndrome X	0.00241	0.0129	CcSEcCtD
Alitretinoin—Neutropenia—Metformin—metabolic syndrome X	0.00235	0.0125	CcSEcCtD
Alitretinoin—Upper respiratory tract infection—Metformin—metabolic syndrome X	0.00233	0.0125	CcSEcCtD
Alitretinoin—RXRB—liver—metabolic syndrome X	0.00225	0.0603	CbGeAlD
Alitretinoin—Infestation NOS—Metformin—metabolic syndrome X	0.00224	0.012	CcSEcCtD
Alitretinoin—Infestation—Metformin—metabolic syndrome X	0.00224	0.012	CcSEcCtD
Alitretinoin—Drowsiness—Metformin—metabolic syndrome X	0.00224	0.012	CcSEcCtD
Alitretinoin—Neuropathy peripheral—Metformin—metabolic syndrome X	0.00219	0.0117	CcSEcCtD
Alitretinoin—Hepatitis—Metformin—metabolic syndrome X	0.00201	0.0107	CcSEcCtD
Alitretinoin—Hypoaesthesia—Metformin—metabolic syndrome X	0.002	0.0107	CcSEcCtD
Alitretinoin—Oedema peripheral—Metformin—metabolic syndrome X	0.00198	0.0106	CcSEcCtD
Alitretinoin—Acitretin—ALB—metabolic syndrome X	0.00188	0.0993	CrCbGaD
Alitretinoin—Eye disorder—Metformin—metabolic syndrome X	0.00188	0.01	CcSEcCtD
Alitretinoin—RARA—liver—metabolic syndrome X	0.00188	0.0503	CbGeAlD
Alitretinoin—Flushing—Metformin—metabolic syndrome X	0.00186	0.00996	CcSEcCtD
Alitretinoin—Angiopathy—Metformin—metabolic syndrome X	0.00182	0.00974	CcSEcCtD
Alitretinoin—Chills—Metformin—metabolic syndrome X	0.0018	0.00963	CcSEcCtD
Alitretinoin—Malnutrition—Metformin—metabolic syndrome X	0.00175	0.00934	CcSEcCtD
Alitretinoin—Erythema—Metformin—metabolic syndrome X	0.00175	0.00934	CcSEcCtD
Alitretinoin—Flatulence—Metformin—metabolic syndrome X	0.00172	0.00921	CcSEcCtD
Alitretinoin—Vision blurred—Metformin—metabolic syndrome X	0.00165	0.00881	CcSEcCtD
Alitretinoin—Tremor—Metformin—metabolic syndrome X	0.00164	0.00875	CcSEcCtD
Alitretinoin—Ill-defined disorder—Metformin—metabolic syndrome X	0.00162	0.00867	CcSEcCtD
Alitretinoin—Malaise—Metformin—metabolic syndrome X	0.00158	0.00843	CcSEcCtD
Alitretinoin—Syncope—Metformin—metabolic syndrome X	0.00157	0.00838	CcSEcCtD
Alitretinoin—Palpitations—Metformin—metabolic syndrome X	0.00155	0.00826	CcSEcCtD
Alitretinoin—Loss of consciousness—Metformin—metabolic syndrome X	0.00154	0.00821	CcSEcCtD
Alitretinoin—Hypertension—Metformin—metabolic syndrome X	0.00151	0.00807	CcSEcCtD
Alitretinoin—Chest pain—Metformin—metabolic syndrome X	0.00149	0.00795	CcSEcCtD
Alitretinoin—Myalgia—Metformin—metabolic syndrome X	0.00149	0.00795	CcSEcCtD
Alitretinoin—Unspecified disorder of skin and subcutaneous tissue—Metformin—metabolic syndrome X	0.00148	0.0079	CcSEcCtD
Alitretinoin—Discomfort—Metformin—metabolic syndrome X	0.00147	0.00786	CcSEcCtD
Alitretinoin—Oedema—Metformin—metabolic syndrome X	0.00143	0.00763	CcSEcCtD
Alitretinoin—Infection—Metformin—metabolic syndrome X	0.00142	0.00758	CcSEcCtD
Alitretinoin—Shock—Metformin—metabolic syndrome X	0.0014	0.0075	CcSEcCtD
Alitretinoin—Nervous system disorder—Metformin—metabolic syndrome X	0.0014	0.00748	CcSEcCtD
Alitretinoin—Thrombocytopenia—Metformin—metabolic syndrome X	0.0014	0.00747	CcSEcCtD
Alitretinoin—Skin disorder—Metformin—metabolic syndrome X	0.00139	0.00741	CcSEcCtD
Alitretinoin—Hyperhidrosis—Metformin—metabolic syndrome X	0.00138	0.00737	CcSEcCtD
Alitretinoin—Anorexia—Metformin—metabolic syndrome X	0.00136	0.00727	CcSEcCtD
Alitretinoin—Hypotension—Metformin—metabolic syndrome X	0.00133	0.00713	CcSEcCtD
Alitretinoin—Musculoskeletal discomfort—Metformin—metabolic syndrome X	0.0013	0.00695	CcSEcCtD
Alitretinoin—ABCB1—blood vessel—metabolic syndrome X	0.00129	0.0347	CbGeAlD
Alitretinoin—Paraesthesia—Metformin—metabolic syndrome X	0.00128	0.00685	CcSEcCtD
Alitretinoin—Dyspnoea—Metformin—metabolic syndrome X	0.00127	0.0068	CcSEcCtD
Alitretinoin—Somnolence—Metformin—metabolic syndrome X	0.00127	0.00678	CcSEcCtD
Alitretinoin—Dyspepsia—Metformin—metabolic syndrome X	0.00126	0.00671	CcSEcCtD
Alitretinoin—Decreased appetite—Metformin—metabolic syndrome X	0.00124	0.00663	CcSEcCtD
Alitretinoin—Gastrointestinal disorder—Metformin—metabolic syndrome X	0.00123	0.00658	CcSEcCtD
Alitretinoin—Fatigue—Metformin—metabolic syndrome X	0.00123	0.00657	CcSEcCtD
Alitretinoin—Constipation—Metformin—metabolic syndrome X	0.00122	0.00652	CcSEcCtD
Alitretinoin—Feeling abnormal—Metformin—metabolic syndrome X	0.00118	0.00628	CcSEcCtD
Alitretinoin—Gastrointestinal pain—Metformin—metabolic syndrome X	0.00117	0.00624	CcSEcCtD
Alitretinoin—Urticaria—Metformin—metabolic syndrome X	0.00113	0.00606	CcSEcCtD
Alitretinoin—Abdominal pain—Metformin—metabolic syndrome X	0.00113	0.00603	CcSEcCtD
Alitretinoin—Asthenia—Metformin—metabolic syndrome X	0.00102	0.00547	CcSEcCtD
Alitretinoin—Pruritus—Metformin—metabolic syndrome X	0.00101	0.00539	CcSEcCtD
Alitretinoin—Diarrhoea—Metformin—metabolic syndrome X	0.000976	0.00522	CcSEcCtD
Alitretinoin—Dizziness—Metformin—metabolic syndrome X	0.000944	0.00504	CcSEcCtD
Alitretinoin—Vomiting—Metformin—metabolic syndrome X	0.000907	0.00485	CcSEcCtD
Alitretinoin—Rash—Metformin—metabolic syndrome X	0.0009	0.00481	CcSEcCtD
Alitretinoin—Dermatitis—Metformin—metabolic syndrome X	0.000899	0.0048	CcSEcCtD
Alitretinoin—Headache—Metformin—metabolic syndrome X	0.000894	0.00478	CcSEcCtD
Alitretinoin—Nausea—Metformin—metabolic syndrome X	0.000848	0.00453	CcSEcCtD
Alitretinoin—CYP1A2—liver—metabolic syndrome X	0.000695	0.0187	CbGeAlD
Alitretinoin—ABCB1—cardiovascular system—metabolic syndrome X	0.000576	0.0155	CbGeAlD
Alitretinoin—ABCB1—kidney—metabolic syndrome X	0.000564	0.0151	CbGeAlD
Alitretinoin—ABCB1—adipose tissue—metabolic syndrome X	0.000508	0.0136	CbGeAlD
Alitretinoin—ABCB1—liver—metabolic syndrome X	0.000356	0.00956	CbGeAlD
Alitretinoin—CRABP1—Metabolism—APOE—metabolic syndrome X	0.000124	0.000164	CbGpPWpGaD
Alitretinoin—RXRA—NRF2 pathway—TGFB1—metabolic syndrome X	0.000124	0.000164	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—APOA1—metabolic syndrome X	0.000123	0.000162	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—APOA1—metabolic syndrome X	0.000123	0.000162	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SIRT1—metabolic syndrome X	0.000123	0.000162	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	0.000122	0.000162	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—NR3C1—metabolic syndrome X	0.000122	0.000161	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SIRT1—metabolic syndrome X	0.000118	0.000156	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SIRT1—metabolic syndrome X	0.000118	0.000156	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—G6PC2—metabolic syndrome X	0.000115	0.000152	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—FABP4—metabolic syndrome X	0.000115	0.000152	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARA—metabolic syndrome X	0.000114	0.00015	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—NR3C1—metabolic syndrome X	0.000113	0.000149	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LPL—metabolic syndrome X	0.000113	0.000149	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—NR3C1—metabolic syndrome X	0.000111	0.000147	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—NR3C1—metabolic syndrome X	0.000109	0.000144	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HSD11B1—metabolic syndrome X	0.000109	0.000144	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PPARG—metabolic syndrome X	0.000108	0.000143	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PPARG—metabolic syndrome X	0.000108	0.000143	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—CD36—metabolic syndrome X	0.000107	0.000142	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—INS—metabolic syndrome X	0.000106	0.00014	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—INS—metabolic syndrome X	0.000106	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARA—metabolic syndrome X	0.000106	0.00014	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	0.000106	0.00014	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—NR3C1—metabolic syndrome X	0.000104	0.000138	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—NR3C1—metabolic syndrome X	0.000104	0.000138	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARA—metabolic syndrome X	0.000104	0.000138	CbGpPWpGaD
Alitretinoin—CYP1A2—Biological oxidations—GGT1—metabolic syndrome X	0.000103	0.000137	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—EPHX2—metabolic syndrome X	0.000103	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Adipogenesis—IL6—metabolic syndrome X	0.000103	0.000136	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	0.000103	0.000136	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—metabolic syndrome X	0.000103	0.000136	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARA—metabolic syndrome X	0.000102	0.000135	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	0.000101	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—APOB—metabolic syndrome X	0.0001	0.000133	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	0.0001	0.000133	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—metabolic syndrome X	9.99e-05	0.000132	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARA—metabolic syndrome X	9.98e-05	0.000132	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—metabolic syndrome X	9.83e-05	0.00013	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARA—metabolic syndrome X	9.79e-05	0.000129	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARA—metabolic syndrome X	9.79e-05	0.000129	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—ALB—metabolic syndrome X	9.74e-05	0.000129	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—ALB—metabolic syndrome X	9.74e-05	0.000129	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—G6PD—metabolic syndrome X	9.71e-05	0.000128	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	9.58e-05	0.000127	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HDAC3—metabolic syndrome X	9.48e-05	0.000125	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—LEP—metabolic syndrome X	9.47e-05	0.000125	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—PPARG—metabolic syndrome X	9.41e-05	0.000124	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	9.37e-05	0.000124	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—metabolic syndrome X	9.33e-05	0.000123	CbGpPWpGaD
Alitretinoin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—metabolic syndrome X	9.33e-05	0.000123	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—NOS3—metabolic syndrome X	9.32e-05	0.000123	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—NOS3—metabolic syndrome X	9.32e-05	0.000123	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LPA—metabolic syndrome X	9.27e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCKR—metabolic syndrome X	9.27e-05	0.000122	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G6—metabolic syndrome X	8.97e-05	0.000119	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	8.91e-05	0.000118	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA5—metabolic syndrome X	8.88e-05	0.000117	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—PPARG—metabolic syndrome X	8.76e-05	0.000116	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	8.63e-05	0.000114	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—PPARG—metabolic syndrome X	8.61e-05	0.000114	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—PTGS2—metabolic syndrome X	8.52e-05	0.000113	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—PTGS2—metabolic syndrome X	8.52e-05	0.000113	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—SERPINE1—metabolic syndrome X	8.48e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	8.47e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	8.45e-05	0.000112	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—PPARG—metabolic syndrome X	8.44e-05	0.000112	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	8.36e-05	0.00011	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—TRIB3—metabolic syndrome X	8.26e-05	0.000109	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—PPARG—metabolic syndrome X	8.25e-05	0.000109	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—FABP4—metabolic syndrome X	8.23e-05	0.000109	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TGFB1—metabolic syndrome X	8.12e-05	0.000107	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—PPARG—metabolic syndrome X	8.09e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—PPARG—metabolic syndrome X	8.09e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—INS—metabolic syndrome X	8.09e-05	0.000107	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	7.95e-05	0.000105	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GCKR—metabolic syndrome X	7.91e-05	0.000104	CbGpPWpGaD
Alitretinoin—RXRA—Generic Transcription Pathway—SERPINE1—metabolic syndrome X	7.89e-05	0.000104	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HSD11B1—metabolic syndrome X	7.81e-05	0.000103	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—SERPINE1—metabolic syndrome X	7.75e-05	0.000102	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—SERPINE1—metabolic syndrome X	7.6e-05	0.000101	CbGpPWpGaD
Alitretinoin—ABCB1—Allograft Rejection—TNF—metabolic syndrome X	7.58e-05	0.0001	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NAMPT—metabolic syndrome X	7.41e-05	9.79e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	7.36e-05	9.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LIPC—metabolic syndrome X	7.36e-05	9.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GCK—metabolic syndrome X	7.36e-05	9.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOC3—metabolic syndrome X	7.31e-05	9.67e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—SERPINE1—metabolic syndrome X	7.29e-05	9.64e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—SERPINE1—metabolic syndrome X	7.29e-05	9.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CETP—metabolic syndrome X	7.1e-05	9.39e-05	CbGpPWpGaD
Alitretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	6.97e-05	9.21e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SCARB1—metabolic syndrome X	6.8e-05	8.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HDAC3—metabolic syndrome X	6.79e-05	8.97e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—metabolic syndrome X	6.69e-05	8.84e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPA—metabolic syndrome X	6.64e-05	8.77e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	6.62e-05	8.75e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SREBF1—metabolic syndrome X	6.6e-05	8.73e-05	CbGpPWpGaD
Alitretinoin—ABCB1—HIF-1-alpha transcription factor network—AKT1—metabolic syndrome X	6.52e-05	8.62e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FMO3—metabolic syndrome X	6.45e-05	8.52e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—metabolic syndrome X	6.43e-05	8.5e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—HMGCR—metabolic syndrome X	6.42e-05	8.49e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT2—metabolic syndrome X	6.42e-05	8.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA5—metabolic syndrome X	6.36e-05	8.41e-05	CbGpPWpGaD
Alitretinoin—RXRA—Transmembrane transport of small molecules—ALB—metabolic syndrome X	6.3e-05	8.32e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—GCK—metabolic syndrome X	6.28e-05	8.3e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SIRT1—metabolic syndrome X	6.14e-05	8.11e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—CETP—metabolic syndrome X	6.06e-05	8.01e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—TRIB3—metabolic syndrome X	5.92e-05	7.82e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	5.79e-05	7.66e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—MLXIPL—metabolic syndrome X	5.75e-05	7.59e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—EPHX2—metabolic syndrome X	5.75e-05	7.59e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ABCA1—metabolic syndrome X	5.72e-05	7.57e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—SLC2A4—metabolic syndrome X	5.72e-05	7.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—metabolic syndrome X	5.54e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GOT1—metabolic syndrome X	5.54e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—GGT1—metabolic syndrome X	5.54e-05	7.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—NR3C1—metabolic syndrome X	5.45e-05	7.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—G6PC2—metabolic syndrome X	5.4e-05	7.14e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—metabolic syndrome X	5.27e-05	6.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOC3—metabolic syndrome X	5.24e-05	6.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FMO3—metabolic syndrome X	5.15e-05	6.8e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARA—metabolic syndrome X	5.1e-05	6.74e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CETP—metabolic syndrome X	5.09e-05	6.72e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—SLC2A4—metabolic syndrome X	4.88e-05	6.46e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—metabolic syndrome X	4.87e-05	6.44e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—SREBF1—metabolic syndrome X	4.73e-05	6.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOB—metabolic syndrome X	4.7e-05	6.22e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TGFB1—metabolic syndrome X	4.69e-05	6.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—HMGCR—metabolic syndrome X	4.6e-05	6.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—FABP4—metabolic syndrome X	4.59e-05	6.07e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—MLXIPL—metabolic syndrome X	4.59e-05	6.06e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—EPHX2—metabolic syndrome X	4.59e-05	6.06e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PLA2G4A—metabolic syndrome X	4.58e-05	6.05e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—LPL—metabolic syndrome X	4.49e-05	5.94e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—TNF—metabolic syndrome X	4.38e-05	5.79e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HSD11B1—metabolic syndrome X	4.35e-05	5.76e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—G6PC2—metabolic syndrome X	4.31e-05	5.7e-05	CbGpPWpGaD
Alitretinoin—CRABP1—Metabolism—AKT1—metabolic syndrome X	4.28e-05	5.66e-05	CbGpPWpGaD
Alitretinoin—CRABP2—Metabolism—AKT1—metabolic syndrome X	4.28e-05	5.66e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—CD36—metabolic syndrome X	4.27e-05	5.64e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—PPARG—metabolic syndrome X	4.22e-05	5.57e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—metabolic syndrome X	4.1e-05	5.42e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOB—metabolic syndrome X	4.01e-05	5.3e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—metabolic syndrome X	4.01e-05	5.3e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—metabolic syndrome X	3.97e-05	5.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARA—metabolic syndrome X	3.97e-05	5.24e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—G6PD—metabolic syndrome X	3.88e-05	5.13e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AGT—metabolic syndrome X	3.84e-05	5.08e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—SERPINE1—metabolic syndrome X	3.8e-05	5.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HDAC3—metabolic syndrome X	3.79e-05	5.01e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOE—metabolic syndrome X	3.77e-05	4.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—metabolic syndrome X	3.74e-05	4.95e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—APOA1—metabolic syndrome X	3.72e-05	4.92e-05	CbGpPWpGaD
Alitretinoin—RARG—Gene Expression—AKT1—metabolic syndrome X	3.72e-05	4.92e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPA—metabolic syndrome X	3.7e-05	4.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCKR—metabolic syndrome X	3.7e-05	4.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—FABP4—metabolic syndrome X	3.67e-05	4.85e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G6—metabolic syndrome X	3.59e-05	4.74e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA5—metabolic syndrome X	3.55e-05	4.69e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—IL6—metabolic syndrome X	3.53e-05	4.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HSD11B1—metabolic syndrome X	3.48e-05	4.59e-05	CbGpPWpGaD
Alitretinoin—RXRG—Gene Expression—AKT1—metabolic syndrome X	3.4e-05	4.5e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—PPARA—metabolic syndrome X	3.39e-05	4.47e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOB—metabolic syndrome X	3.37e-05	4.45e-05	CbGpPWpGaD
Alitretinoin—RARB—Gene Expression—AKT1—metabolic syndrome X	3.34e-05	4.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—TRIB3—metabolic syndrome X	3.3e-05	4.36e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PPARG—metabolic syndrome X	3.28e-05	4.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—metabolic syndrome X	3.28e-05	4.33e-05	CbGpPWpGaD
Alitretinoin—RXRA—Developmental Biology—AKT1—metabolic syndrome X	3.26e-05	4.31e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—LPL—metabolic syndrome X	3.22e-05	4.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—INS—metabolic syndrome X	3.22e-05	4.25e-05	CbGpPWpGaD
Alitretinoin—RARA—Gene Expression—AKT1—metabolic syndrome X	3.2e-05	4.23e-05	CbGpPWpGaD
Alitretinoin—RXRB—Gene Expression—AKT1—metabolic syndrome X	3.2e-05	4.23e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—APOA1—metabolic syndrome X	3.18e-05	4.2e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—G6PD—metabolic syndrome X	3.1e-05	4.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—CD36—metabolic syndrome X	3.06e-05	4.04e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HDAC3—metabolic syndrome X	3.02e-05	4e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NAMPT—metabolic syndrome X	2.96e-05	3.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPA—metabolic syndrome X	2.96e-05	3.91e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCKR—metabolic syndrome X	2.96e-05	3.91e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—ALB—metabolic syndrome X	2.95e-05	3.9e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LIPC—metabolic syndrome X	2.94e-05	3.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GCK—metabolic syndrome X	2.94e-05	3.89e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOC3—metabolic syndrome X	2.92e-05	3.86e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G6—metabolic syndrome X	2.86e-05	3.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—metabolic syndrome X	2.84e-05	3.76e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CETP—metabolic syndrome X	2.84e-05	3.75e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA5—metabolic syndrome X	2.83e-05	3.75e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—NOS3—metabolic syndrome X	2.82e-05	3.73e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—metabolic syndrome X	2.79e-05	3.68e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—AGT—metabolic syndrome X	2.75e-05	3.64e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SCARB1—metabolic syndrome X	2.72e-05	3.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—metabolic syndrome X	2.7e-05	3.56e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—metabolic syndrome X	2.67e-05	3.52e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SREBF1—metabolic syndrome X	2.64e-05	3.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—TRIB3—metabolic syndrome X	2.63e-05	3.48e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—PTGS2—metabolic syndrome X	2.58e-05	3.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—HMGCR—metabolic syndrome X	2.57e-05	3.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT2—metabolic syndrome X	2.57e-05	3.39e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Transmembrane transport of small molecules—ALB—metabolic syndrome X	2.52e-05	3.33e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NAMPT—metabolic syndrome X	2.36e-05	3.12e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—metabolic syndrome X	2.35e-05	3.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LIPC—metabolic syndrome X	2.35e-05	3.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GCK—metabolic syndrome X	2.35e-05	3.1e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOC3—metabolic syndrome X	2.33e-05	3.08e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ABCA1—metabolic syndrome X	2.29e-05	3.02e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—SLC2A4—metabolic syndrome X	2.29e-05	3.02e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CETP—metabolic syndrome X	2.27e-05	2.99e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GGT1—metabolic syndrome X	2.22e-05	2.93e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—GOT1—metabolic syndrome X	2.22e-05	2.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SCARB1—metabolic syndrome X	2.17e-05	2.87e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—metabolic syndrome X	2.11e-05	2.79e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SREBF1—metabolic syndrome X	2.11e-05	2.78e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—HMGCR—metabolic syndrome X	2.05e-05	2.71e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT2—metabolic syndrome X	2.05e-05	2.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOB—metabolic syndrome X	1.88e-05	2.48e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—metabolic syndrome X	1.85e-05	2.44e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PLA2G4A—metabolic syndrome X	1.83e-05	2.42e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ABCA1—metabolic syndrome X	1.83e-05	2.41e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—SLC2A4—metabolic syndrome X	1.83e-05	2.41e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—LPL—metabolic syndrome X	1.8e-05	2.37e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GOT1—metabolic syndrome X	1.77e-05	2.34e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—GGT1—metabolic syndrome X	1.77e-05	2.34e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—CD36—metabolic syndrome X	1.71e-05	2.25e-05	CbGpPWpGaD
Alitretinoin—RXRA—Gene Expression—AKT1—metabolic syndrome X	1.67e-05	2.2e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARA—metabolic syndrome X	1.59e-05	2.1e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AGT—metabolic syndrome X	1.54e-05	2.03e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOE—metabolic syndrome X	1.5e-05	1.99e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOB—metabolic syndrome X	1.5e-05	1.98e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—APOA1—metabolic syndrome X	1.49e-05	1.97e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PLA2G4A—metabolic syndrome X	1.46e-05	1.93e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—LPL—metabolic syndrome X	1.43e-05	1.89e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—CD36—metabolic syndrome X	1.36e-05	1.8e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PPARG—metabolic syndrome X	1.31e-05	1.73e-05	CbGpPWpGaD
Alitretinoin—RXRA—Metabolism—AKT1—metabolic syndrome X	1.3e-05	1.71e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—INS—metabolic syndrome X	1.29e-05	1.7e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARA—metabolic syndrome X	1.27e-05	1.67e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AGT—metabolic syndrome X	1.23e-05	1.62e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOE—metabolic syndrome X	1.2e-05	1.59e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—APOA1—metabolic syndrome X	1.19e-05	1.57e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—ALB—metabolic syndrome X	1.18e-05	1.56e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—NOS3—metabolic syndrome X	1.13e-05	1.49e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PPARG—metabolic syndrome X	1.05e-05	1.38e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—PTGS2—metabolic syndrome X	1.03e-05	1.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—INS—metabolic syndrome X	1.03e-05	1.36e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—ALB—metabolic syndrome X	9.41e-06	1.24e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—NOS3—metabolic syndrome X	9e-06	1.19e-05	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—PTGS2—metabolic syndrome X	8.23e-06	1.09e-05	CbGpPWpGaD
Alitretinoin—ABCB1—Metabolism—AKT1—metabolic syndrome X	5.18e-06	6.85e-06	CbGpPWpGaD
Alitretinoin—CYP1A2—Metabolism—AKT1—metabolic syndrome X	4.14e-06	5.47e-06	CbGpPWpGaD
